康美德
CNMD
46.72
-0.42
-0.89%
康美德
US · CNMD
#3018 按市值排名
上市于 1970
46.72
-0.42
-0.89%
实时 - 追踪5344个代码 - 心跳于453秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了3家。
- 机构持股总比例下降了0.1个百分点。
机构持股
- 机构持股比例
- 114.33% -0.14pp
- 机构数量
- 301 -3
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund101.42%
Hedge Fund6.92%
Public Company3.30%
Government Pension Fund1.22%
Private Company1.14%
Individual/Insider0.89%
Insurance Company0.15%
主要股东 截至 2026-06-30
BlackRock
16.10% · 4.82M 股
EARNEST Partners, LLC
8.36% · 2.51M 股
Vanguard Portfolio Management, LLC
7.31% · 2.19M 股
Fuller & Thaler Asset Management, Inc.
5.27% · 1.58M 股
Vanguard Capital Management, LLC
5.20% · 1.56M 股
State Street Global Advisors
4.73% · 1.42M 股
Dimensional Fund Advisors
4.40% · 1.32M 股
Managed Account Advisors LLC
3.78% · 1.13M 股
SEI Investments Company
3.30% · 988.15K 股
Invenomic Capital Management LP
2.81% · 842.16K 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 37次买入 · 7次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Curt Hartman | Chairperson & CEO | 0.31% |
| Heather Cohen | Executive VP and Chief Human Resources & Legal Officer | 0.14% |
| John Workman | Independent Director | 0.07% |
| David Bronson | Independent Director | 0.06% |
| Charles Farkas | Independent Director | 0.05% |
| Stephan Epinette | -- | 0.05% |
| Martha Aronson | Lead Independent Director | 0.05% |
| Patrick Beyer | President of International & Global Orthopedics | 0.04% |
| Brian Concannon | Independent Director | 0.03% |
| Barbara Schwarzentraub | Independent Director | 0.02% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-07 | Kim Kelderman | Director | Derivative Exercise and Retained | +500 | -- |
| 2026-07-14 | John Gallagher | Executive VP, CFO and Principal Financial & Accounting Officer | Other Derivative Acquisition | +30,536 | $42.79 |
| 2026-07-14 | John Gallagher | Executive VP, CFO and Principal Financial & Accounting Officer | Other Derivative Acquisition | +61,929 | -- |
| 2026-07-14 | John Gallagher | Executive VP, CFO and Principal Financial & Accounting Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-06-30 | Jeffrey Mirviss | Director | Other Derivative Acquisition | +5,603 | -- |
| 2026-06-30 | Jeffrey Mirviss | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-06-30 | Celine Martin | Director | Other Derivative Acquisition | +5,603 | -- |
| 2026-06-30 | Celine Martin | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-06-01 | David Bronson | Independent Director | Derivative Exercise and Retained | +668 | -- |
| 2026-06-01 | Laverne Council | Independent Director | Derivative Exercise and Retained | +668 | -- |
| 2026-06-01 | Mark Kaye | Director | Derivative Exercise and Retained | +668 | -- |
| 2026-06-01 | Charles Farkas | Independent Director | Derivative Exercise and Retained | +668 | -- |
| 2026-06-01 | Barbara Schwarzentraub | Independent Director | Derivative Exercise and Retained | +668 | -- |
| 2026-05-31 | David Bronson | Independent Director | Other Derivative Acquisition | +5,772 | -- |
| 2026-05-31 | Kim Kelderman | Director | Other Derivative Acquisition | +5,772 | -- |
| 2026-05-31 | Laverne Council | Independent Director | Other Derivative Acquisition | +5,772 | -- |
| 2026-05-31 | Mark Kaye | Director | Other Derivative Acquisition | +5,772 | -- |
| 2026-05-31 | Charles Farkas | Independent Director | Other Derivative Acquisition | +5,772 | -- |
| 2026-05-31 | Barbara Schwarzentraub | Independent Director | Other Derivative Acquisition | +5,772 | -- |
| 2026-05-31 | Kimberly Lockwood | Interim Corporate Controller | Initial Statement of Beneficial | 0 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
康美德 讨论区 0 条评论